UK
Study reveals doctors political views as BMA backs Brexit final say
July 31, 2018Manufacturing and Production BMA, NHS, UK, brexit, doctors, politics
The London-based British Medical Association (BMA), which represents 156,000 doctors and 19,000 medical students, is supporting calls for a ‘final …
Army to ferry medicines in case of no-deal Brexit
July 30, 2018Sales and Marketing UK, army, brexit, medicines, pharma, politics, supply chains
Ministers have established plans to use the army to deliver medicines, food and fuel in the event of a no-deal …
MPs vote to stay in EMA after Brexit
July 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote
British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …
NICE approves treatment for rare and deadly childhood cancer
July 11, 2018Sales and Marketing Cancer, NICE, UK, neuroblastoma, pharma
NICE has recommended that monoclonal antibody dinutuximab beta be used in treating high-risk neuroblastoma – a rare and deadly form …
The July/August issue of Pharmafocus is now live!
July 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma
The new July/August edition of Pharmafocus is now available to read online.
GW Pharma’s Epidiolex becomes first cannabis-based medicine available in US
June 26, 2018Manufacturing and Production, Sales and Marketing FDA, GW Pharma, Lennox-Gastaut syndrome, UK, US, cannabidiol, cannabis
In what could prove to be a pivotal decision, UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution …
NICE backs Sanofi’s new treatment for atopic dermatitis
June 22, 2018Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma
NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …
Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS
June 22, 2018Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma
Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …
Elderly cancer cases to increase 80% by 2035, says CRUK
June 21, 2018Medical Communications, Research and Development CRUK, Cancer, Cancer Research UK, NHS, UK, pharma
A new report from Cancer Research UK has indicated that the number of UK citizens over the age of 75 …
UK demand for mental health apps soars 566% since 2014
June 13, 2018Medical Communications, Research and Development UK, apps, mental health, pharma
A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
One in 25 English children are severely obese by secondary school, study finds
May 29, 2018Manufacturing and Production, Research and Development England, UK, childhood obesity, obesity, pharma
A new analysis of Public Health England figures by the Local Government Association (LGA) has revealed that one in 25 …
Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis
May 11, 2018Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis
NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …
BenevolentAI names former UK Minister as new Group CEO
May 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, BenevolentAI, Facebook, UK, appointment, google
Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …
The UK sugar tax: A sweet or sour move?
May 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax
Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
